###begin article-title 0
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
The Type 2 Diabetes Associated Minor Allele of rs2237895 KCNQ1 Associates with Reduced Insulin Release Following an Oral Glucose Load
###end article-title 0
###begin p 1
Conceived and designed the experiments: JH GA TH OBP. Performed the experiments: JH KB TSJ. Analyzed the data: JH KB. Contributed reagents/materials/analysis tools: HU TSJ CP KBJ AS TL SB SM TH OBP. Wrote the paper: JH GA TH OBP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
Polymorphisms in the potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1) have recently been reported to associate with type 2 diabetes. The primary aim of the present study was to investigate the putative impact of these KCNQ1 polymorphisms (rs2283228, rs2237892, rs2237895, and rs2237897) on estimates of glucose stimulated insulin release.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
Genotypes were examined for associations with serum insulin levels following an oral glucose tolerance test (OGTT) in a population-based sample of 6,039 middle-aged and treatment-naive individuals. Insulin release indices estimated from the OGTT and the interplay between insulin sensitivity and insulin release were investigated using linear regression and Hotelling T2 analyses.
###end p 5
###begin p 6
Applying an additive genetic model the minor C-allele of rs2237895 was associated with reduced serum insulin levels 30 min (mean+/-SD: (CC) 277+/-160 vs. (AC) 280+/-164 vs. (AA) 299+/-200 pmol/l, p = 0.008) after an oral glucose load, insulinogenic index (29.6+/-17.4 vs. 30.2+/-18.7vs. 32.2+/-22.1, p = 0.007), incremental area under the insulin curve (20,477+/-12,491 vs. 20,503+/-12,386 vs. 21,810+/-14,685, p = 0.02) among the 4,568 individuals who were glucose tolerant. Adjustment for the degree of insulin sensitivity had no effect on the measures of reduced insulin release. The rs2237895 genotype had a similar impact in the total sample of treatment-naive individuals. No association with measures of insulin release were identified for the less common diabetes risk alleles of rs2237892, rs2237897, or rs2283228.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
The minor C-allele of rs2237895 of KCNQ1, which has a prevalence of about 42% among Caucasians was associated with reduced measures of insulin release following an oral glucose load suggesting that the increased risk of type 2 diabetes, previously reported for this variant, likely is mediated through an impaired beta cell function.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 196 199 196 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Alberti1">[1]</xref>
###xml 554 557 554 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 569 570 569 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
###xml 604 606 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 616 619 616 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Jacobson1">[2]</xref>
###xml 620 623 620 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Zhang1">[7]</xref>
###xml 816 818 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 829 836 829 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CACNA1E</italic>
###xml 843 846 843 846 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 937 940 937 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Gloyn1">[8]</xref>
###xml 942 945 942 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Holmkvist1">[9]</xref>
###xml 1110 1114 1110 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Saxena1">[10]</xref>
###xml 1115 1119 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Zeggini1">[14]</xref>
###xml 1280 1285 1280 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 1439 1442 1439 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 1488 1491 1488 1491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 1493 1497 1493 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 1604 1607 1604 1607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;26</sup>
###xml 1654 1657 1654 1657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;42</sup>
###xml 1657 1661 1657 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Yasuda1">[16]</xref>
Type 2 diabetes is a common complex disorder, characterised by chronic hyperglycemia as the result of an incapacity of the pancreatic beta cells to compensate for the degree of insulin resistance [1]. Glucose-stimulated insulin secretion is biphasic; impaired or absent first-phase insulin secretion is an early feature of type 2 diabetes, while second-phase insulin secretion deteriorates during progression of the disease. Biphasic insulin secretion is triggered by electrical signalling in the beta cell as a result of a functional interplay between KATP channels, KV-channels and voltage-dependent Ca2+ channels [2]-[7]. Hence, genes involved in maintaining and regulating the electrogradient in the beta cells are plausible candidate genes for type 2 diabetes. To date, genetic variation in voltage-dependent Ca2+ channels (CACNA1E) and KATP (KCNJ11) channels have been shown to influence insulin secretion and type 2 diabetes risk [8], [9], and genome-wide association studies (GWAS) for type 2 diabetes in Caucasians have proven the importance of genes coding for proteins involved in insulin secretion [10]-[14]. Two independent GWAS in Japanese individuals have identified a novel type 2 diabetes gene: the potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1), and for the two studies, the association was replicated in Danish and Singaporean individuals (meta-analysis: rs2237895 OR = 1.23 (1.18-1.29), p<1.0x10-16 and rs2237897 OR = 1.33 (1.24-1.41), p<1.0x10-16) [15], and in Chinese, Korean and Swedish individuals (meta-analysis: rs2237895 OR = 1.31 (1.25-138), p = 6.1x10-26, and rs2237892 OR = 1.40 (1.34-1.47), p<1.7x10-42[16].
###end p 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1C</italic>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Nielsen1">[17]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Mori1">[18]</xref>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Neyroud1">[19]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Chouabe1">[20]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-NewtonCheh1">[21]</xref>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Pfeufer1">[22]</xref>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 574 576 570 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ks</sub>
###xml 587 588 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
###xml 707 711 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 713 717 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Robbins1">[23]</xref>
###xml 742 743 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
###xml 981 985 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Grunnet1">[24]</xref>
###xml 1129 1130 1122 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1326 1330 1319 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Ullrich1">[25]</xref>
###xml 619 624 <span type="species:ncbi:9606">human</span>
KCNQ1 is located on chromosome 11p15.5, a region that also contains other genes which have previously been associated with type 2 diabetes, e.g., CDKN1C[17]. Linkage to type 2 diabetes has similarly been identified at chromosome 11p12-p13 in a Japanese study [18]. Mutations in KCNQ1 are known to cause the autosomal-recessive and -dominant forms of the long QT-syndrome (Jervell and Lange-Nielsen [19] and Romano-Ward [20]), and common variation has also been genome-wide associated with altered QT interval [21], [22]. KCNQ1 encodes the pore-forming alpha-subunit of the IKs-channel (KV7.1) which is expressed in the human heart and pancreas as well as in the kidney, placenta, liver, lung, and intestine [15], [23]. The basal pore of the KV7.1-channel consists of four KCNQ1 subunits, which assemble with different KCNE beta-subunit family members (e.g., KCNE1 in cardiac tissue and KCNE3 in colonic tissue) to form protein complexes with different potassium current properties [24]. From studies in INS-1 cells it has been suggested that KCNQ1 assembles with KCNE2 in insulin-secreting cells, and that blocking of the KCNQ1 K+ channel with the sulphonamide analogue 293B reduces whole beta cell outward currents with 60%, and that the insulin secretion significantly increases in the presence of both 293B and tolbutamide [25].
###end p 11
###begin p 12
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
To test the hypothesis that the recently reported type 2 diabetes-associated variants in KCNQ1 have an effect on insulin release, we investigated rs2283228, rs2237892, rs2237895, and rs2237897 for association with serum insulin levels during an oral glucose tolerance test (OGTT) in a population-based sample of 6,039 middle-aged and treatment-naive Danes.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Effect of the common KCNQ1 rs2237895 on measures of serum insulin release
###end title 14
###begin p 15
###xml 5 10 5 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Yasuda1">[16]</xref>
###xml 167 175 167 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s001">Table S1</xref>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 662 671 662 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s002">Tables S2</xref>
###xml 672 672 672 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s003"/>
###xml 672 672 672 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s004"/>
###xml 672 672 672 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s005"/>
###xml 672 672 672 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s006"/>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s007">S7</xref>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 957 964 957 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005872-t001">Table 1</xref>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005872-t002">2</xref>
###xml 1032 1039 1032 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005872-t001">Table 1</xref>
###xml 1041 1042 1041 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005872-t002">2</xref>
###xml 1061 1062 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 746 758 <span type="species:ncbi:9606">participants</span>
Four KCNQ1 polymorphisms (rs2237892, rs2283228, rs2237895, and rs2237897) previously shown to associate with type 2 diabetes [15], [16] were genotyped in 6,164 Danes (Table S1), who were part of the Danish case-control sample in the study by Unoki et al.[15]. These variants were investigated for an association with type 2 diabetes-related quantitative traits in the population-based Inter99 study sample involving 6,039 treatment-naive middle-aged individuals of whom 4,568 were normal glucose tolerant according to WHO criteria. Three of the variants (rs2237892, rs2283228, and rs2237897) were not associated with type 2 diabetes related quantitative traits (Tables S2-S7). However, both glucose tolerant individuals and treatment-naive study participants of Inter99 with the minor C-allele of KCNQ1 rs2237895 (minor allele frequency = 42.5%) had significantly lower measures of serum insulin and serum C-peptide release under an additive genetic model (Table 1, 2). No differences in insulin resistance (HOMA-IR) were observed (Table 1, 2). Data on D' and r2 for the four SNPs are given in (Table S8).
###end p 15
###begin title 16
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
Anthropometrics and quantitative metabolic traits in 4,239 successfully genotyped individuals with normal glucose tolerance from the population-based Inter99 study sample in relation to the rs2237895 genotypes of KCNQ1.
###end title 16
###begin p 17
The table includes unadjusted mean+/-S.D data. P-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 17
###begin title 18
###xml 223 230 223 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005872-t001">Table 1</xref>
Anthropometrics and quantitative metabolic traits of a total of 5,597 successfully genotyped middle-aged and treatment-naive individuals from the Inter99 sample including the 4,239 glucose-tolerant individuals presented in Table 1.
###end title 18
###begin p 19
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants are stratified according to rs2237895 genotypes of KCNQ1.
###end p 19
###begin p 20
P-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 20
###begin p 21
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 592 600 592 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dominant</sub>
###xml 611 619 611 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005872-g001">Figure 1</xref>
In order to further investigate a putative beta cell abnormality, the interplay between insulin release (Insulinogenic index: I/G30), insulin resistance (Homeostasis model assessment of insulin resistance: HOMA-IR) and the genetic predisposition to type 2 diabetes with KCNQ1 rs2237895, we applied the multivariate Hotelling's T2 method to simultaneously test the effect of genotype on I/G30 and HOMA-IR in the sample of glucose tolerant individuals. Significant multivariate association with the rs2237895 C-risk-allele and the combination of I/G30 and HOMA-IR was demonstrated (p = 0.004; pdominant = 0.004) (Figure 1).
###end p 21
###begin title 22
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
Multivariate analysis on the effect of the minor C-allele of KCNQ1 rs2237895 on insulin release in response to the level of insulin sensitivity in 4,568 glucose tolerant individuals from Inter99.
###end title 22
###begin p 23
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 39 43 39 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Hotelling1">[36]</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
The multivariate method, Hotelling's T2[36], was applied to test the simultaneous effect of genotype on insulinogenic index and HOMA-IR for rs2237895. Two-dimensional standard error of the means of each genotype level for insulinogenic index and HOMA-IR were calculated for KCNQ1 rs2237895. Significant multivariate association with the minor C-allele of rs2237895 was detected under an additive genetic model (p = 0.004) suggesting that the association with insulin release was not dependent on the level of insulin sensitivity but a true beta cell abnormality.
###end p 23
###begin title 24
Discussion
###end title 24
###begin p 25
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Yasuda1">[16]</xref>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 639 647 639 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005872-g001">Figure 1</xref>
Current knowledge of the KCNQ1 protein in INS-1-cells and the association of the KCNQ1 polymorphisms with type 2 diabetes in two large Japanese studies [15], [16] led us to investigate a role for these variants in type 2 diabetes-related quantitative traits (especially serum insulin release) in the population-based Inter99 study sample. Individuals with the minor C-allele of KCNQ1 rs2237895 had significantly reduced estimates of first-phase insulin release as measured by serum insulin concentration at 30 min and I/G30 and the association was not dependent on the level of insulin sensitivity suggesting a true beta cell abnormality (Figure 1).
###end p 25
###begin p 26
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 179 180 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
###xml 255 256 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
###xml 353 356 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-MacDonald1">[4]</xref>
###xml 357 360 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Zhang1">[7]</xref>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Ullrich1">[25]</xref>
###xml 544 552 544 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 955 959 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Veglio1">[26]</xref>
###xml 1058 1063 1058 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 1091 1095 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-NewtonCheh1">[21]</xref>
###xml 1097 1101 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Pfeufer1">[22]</xref>
###xml 1179 1183 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Moss1">[27]</xref>
###xml 202 205 <span type="species:ncbi:10116">rat</span>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
The KV-channels are believed to play an important role in the pancreatic beta cells mediating repolarisation of the membrane terminating Ca2+-influx and insulin secretion, and a KV-channel knock-out in rat islets as well as pharmacological inhibition of KV-channels in mouse beta cells have been reported to enhance glucose-stimulated insulin secretion [4]-[7]. The KV7.1 channel, encoded by KCNQ1, is expressed in INS-1 cells and has been suggested to play an important role in maintaining the membrane potential in these cells [25]. Based on in vitro data and the association with type 2 diabetes, there is compelling evidence suggesting an effect also on type 2 diabetes-related quantitative traits with variation in this gene. In context of the known function of the protein encoded by KCNQ1 it is also interesting to note the potential relationship between an increased risk of sudden cardiac death with unknown etiology in individuals with diabetes [26], supported by recent studies showing genome-wide significant association with common variation in KCNQ1 and QT-interval of the ECG [21], [22], as well as association with the Mendelian long QT syndrome and sudden death [27].
###end p 26
###begin p 27
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Lage1">[28]</xref>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AKAP9</italic>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005872-g002">Figure 2</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Marx1">[29]</xref>
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AKAP9</italic>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Chen1">[30]</xref>
###xml 784 788 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Lester1">[31]</xref>
Furthermore, an in silico protein-protein interaction network analyses, performed as in [28], suggested several interesting protein interactions and pathways that could potentially affect insulin secretion, e.g., AKAP9, encoding the Yotiao-protein (Figure 2). This protein has previously been reported to form a large macromolecular complex with KCNQ1 important in coordinating cAMP-dependent PKA phosphorylation of the KCNQ1-channel [29]. A mutation in AKAP9 has also been shown to cause long QT syndrome subtype 11 by disrupting the binding to KCNQ1 leading to reduced cAMP-stimulated PKA phosphorylation of the KCNQ1-channel and a prolonged repolarization period [30]. In addition, anchoring of PKA to AKAPs is involved in GLP-1-mediated but not glucose-mediated insulin secretion [31].
###end p 27
###begin title 28
KCNQ1 -protein interaction analyses as estimated from bioinformatics-driven protein-protein network analyses including interactions transferred from other organisms by orthology.
###end title 28
###begin p 29
PSMC x - Proteasome 26S subunit, ATPase, x; PSMD x - Proteasome 26S subunit, ATPase, x; PSMB5 - Proteasome subunit, beta-type, 5; AKAP9 - A-Kinase Anchor Protein 9; KCNE x - Potassium Channel, Voltage-gated, ISK-related Subfamily, Member x.
###end p 29
###begin p 30
###xml 18 22 18 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 24 28 24 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Yasuda1">[16]</xref>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 1111 1117 1111 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1C</italic>
###xml 1167 1171 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Nielsen1">[17]</xref>
###xml 1199 1203 1199 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN</italic>
###xml 1212 1220 1212 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/B</italic>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Saxena1">[10]</xref>
###xml 1336 1340 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Sladek1">[12]</xref>
###xml 1342 1346 1342 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Zeggini1">[14]</xref>
###xml 1348 1352 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Grarup1">[32]</xref>
###xml 1408 1413 1408 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 1452 1456 1452 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 1458 1462 1458 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Yasuda1">[16]</xref>
###xml 1500 1505 1500 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 1952 1957 1952 1957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1959 1963 1959 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Tan1">[33]</xref>
###xml 2015 2020 2015 2020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
In recent studies [15], [16] large differences in allele frequencies were observed for KCNQ1 rs2237892, rs2283228, and rs2237897 between Japanese and Scandinavian individuals. Given the low allele frequency for these three variants in our Caucasian population the statistical power to identify an association with type 2 diabetes related quantitative traits with an equal effect size as in the Japanese studies was low. This fact might explain the lack of association with measures of serum insulin release for these variants. However, it could also indicate that these variants are not causative but rather good proxies for the causative variant/s in the Japanese population and poorer proxies in individuals of Scandinavian ancestry. This given, we cannot exclude that rs2237895 is in strong LD with a causative variant/s in this or in another nearby gene in this heavily imprinted and gene-dense region since the selection of these variants were based on previous findings linking them to an increased risk of type 2 diabetes. In this context it is important to notice that polymorphisms in the neighbouring CDKN1C have been associated with increased birth weight [17], and that variation in the CDKN family (CDKN2A/B locus; chromosome 9p21) has been associated with type 2 diabetes in recent GWAS- and GWAS-replication studies [10]-[12], [14], [32]. Thus, given the large allele-frequency differences of KCNQ1 variants observed in previous studies [15], [16], genotyping and re-sequencing of the KCNQ1 locus and nearby loci on chromosome 11p in additional populations may help identifying the causative variant/s explaining the regional association with reduced insulin release and type 2 diabetes. Using the overly conservative Bonferroni correction the present data would not hold for multiple testing, but since the measures of insulin release during the OGTT are highly correlated we believe such corrections are too conservative. Although Tan et al. [33] have also reported association of variation in the KCNQ1 locus and impaired beta-cell function in 3734 Asians additional replication attempts in large independent studies with careful measurements of stimulated insulin release are warranted.
###end p 30
###begin p 31
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
In conclusion, we report insulin sensitivity independent impairment of insulin release following an oral glucose load in a large population of middle-aged treatment naive individuals carrying the type 2 diabetes associated minor C-allele of KCNQ1 rs2237895.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
Subjects
###end title 33
###begin p 34
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Jrgensen1">[34]</xref>
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005872.s001">Table S1</xref>
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Alberti1">[1]</xref>
###xml 643 648 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Unoki1">[15]</xref>
###xml 200 212 <span type="species:ncbi:9606">participants</span>
The four polymorphisms (rs2283228, rs2237892, rs2237895, rs2237897) were genotyped in 6,164 Danes from the population-based Inter99 study sample [34] (Table S1). The glucose tolerance status of these participants were characterised according to WHO criteria [1]; normal glucose tolerance (n = 4,568), impaired fasting glycaemia (n = 508), impaired glucose tolerance (n = 707), or screen-detected T2D (n = 256); 125 had known treated type 2 diabetes and were excluded from the quantitative trait analyses. The glucose tolerant individuals from the Inter99 study sample were part of the Danish control group in the previously published Japanese KCNQ1 case-control study [15].
###end p 34
###begin title 35
Ethics statement
###end title 35
###begin p 36
###xml 4 16 <span type="species:ncbi:9606">participants</span>
###xml 95 107 <span type="species:ncbi:9606">participants</span>
All participants were of Danish nationality and informed written consent was obtained from all participants before participation. The studies were approved by the Ethical Committee of Copenhagen and were in accordance with the principle of the Helsinki Declaration II.
###end p 36
###begin title 37
Biochemical and anthropometric measurements
###end title 37
###begin p 38
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 486 488 486 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1C</sub>
###xml 931 932 931 932 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</sub>
###xml 1149 1150 1149 1150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</sub>
###xml 1309 1313 1309 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Hansen1">[35]</xref>
###xml 320 332 <span type="species:ncbi:9606">participants</span>
Height and body weight were measured in light indoor clothes and without shoes, and BMI was calculated as weight (kg) divided by height squared (m2). Waist circumference was measured in the standing position midway between the iliac crest and the lower costal margin and hip circumference at its maximum. In the Inter99 participants blood samples were drawn after a 12-h overnight fast. Plasma glucose was analysed by a glucose oxidase method (Granutest, Merck, Darmstadt, Germany), HbA1C was measured by ion-exchange high-performance liquid chromatography (normal reference range: 0.041-0.064) and serum insulin (excluding des(31, 32) and intact proinsulin) was measured using the AutoDELFIA insulin kit (Perkin-Elmer/Wallac, Turku, Finland). Serum C-peptide concentrations were measured by a time-resolved fluoroimmunoassay (AutoDELFIA C-peptide kit; Perkin-Elmer/Wallac, Turku, Finland). BIGTT-insulin sensitivity index (BIGTT-SI) and BIGTT-acute insulin response (BIGTT-AIR) use information on sex and BMI combined with analysis of plasma glucose and serum insulin levels at time points 0, 30, and 120 min during an OGTT to provide indices for SI and AIR that highly correlate with these indices obtained during an intra-venous glucose tolerance test. These indices were calculated as described elsewhere [35]. Insulinogenic index (I/G30) is an index of first phase insulin release during an oral glucose challenge and was calculated as fasting serum insulin subtracted from serum insulin at 30 min [pmol/l] divided by plasma glucose at 30 min [mmol/l]. Insulin resistance was determined by the Homeostasis model assessment of insulin resistance (HOMA-IR) and calculated as fasting plasma glucose [mmol/l] multiplied by fasting serum insulin [pmol/l] and divided by 22.5. The disposition index is an index of insulin release in response to insulin resistance and was calculated as I/G30 divided by HOMA-IR. The area under curve for plasma glucose, serum insulin and serum C-peptide were calculated using the trapezoidal method.
###end p 38
###begin title 39
Bioinformatics-driven protein-protein interaction analyses
###end title 39
###begin p 40
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Lage1">[28]</xref>
In an attempt to detect proteins that interact with KCNQ1 we applied protein-protein interaction analyses, performed as detailed in [28].
###end p 40
###begin title 41
Genotyping
###end title 41
###begin p 42
Genotyping was performed using Taqman allelic discrimination (KBiosciences, Herts, UK) with a success rate >96%. Discordance was <0.4% as judged from re-genotyping of 966 random duplicate samples. Allele frequencies were in accordance with HapMap (CEU) data (rs2237895 has not been genotyped in the CEU population) and obeyed Hardy-Weinberg equilibrium (p>0.4).
###end p 42
###begin title 43
Statistical analyses
###end title 43
###begin p 44
A general linear model was used to test for an association with quantitative variables in the groups of normal glucose tolerant and treatment-naive individuals with abnormal glucose regulation (impaired fasting glucose, impaired glucose tolerance and screen-detected type 2 diabetes). Non-normally distributed data (measures of serum insulin release and C-peptides, HOMA-IR, insulinogenic index, disposition index and BIGTT) were logarithmically transformed before analyses. All analyses were adjusted for age, BMI, and sex.
###end p 44
###begin p 45
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 37 41 37 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Hotelling1">[36]</xref>
The multivariate method, Hotelling T2[36], was applied to test the simultaneous effect of genotype on serum insulin release (I/G30) and insulin sensitivity (HOMA-IR) in the Inter99 sample of non-diabetic individuals.
###end p 45
###begin p 46
The statistical power to detect a difference in serum insulin at 30 min was estimated using simulations. We assumed an additive genetic model for both the simulation of the data and for the testing of the data using a linear model. We used the empirical variance of the observed traits to simulate phenotypes from a normal distribution so that the variance across genotypes is drawn from the estimated variance. The power was estimated using 5,000 simulations and with a significance threshold of alpha = 0.05. Based on the different allele frequencies and the 4,568 normal glucose-tolerant individuals, we estimated the effect sizes per allele of quantitative traits for which we had 80 and 90% statistical power, respectively, to detect an association. Depending on allele frequency (4.0-42.5%) and assuming an additive model, we had 80% statistical power to detect an allele-dependent difference of 7.4-2.9% for serum insulin 30 min and 8.1-3.2% for I/G30. Similarly, we had 90% statistical power to detect an 8.4-3.4% and 9.4-3.7% change per allele in serum insulin 30 min and I/G30, respectively.
###end p 46
###begin p 47
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005872-Purcell1">[37]</xref>
The statistical analyses were performed using R version 2.7.2 (available at ), SPSS (version 14.0, Chicago, IL, USA) and PLINK [37]. P-values were not adjusted for multiple hypothesis testing and a p-value of <0.05 was considered statistically significant.
###end p 47
###begin title 48
Supporting Information
###end title 48
###begin p 49
###xml 34 46 <span type="species:ncbi:9606">participants</span>
Clinical characteristics of study participants. Data are means+/-standard deviation. NGT, normal glucose tolerance, IFG, impaired fasting glucose, IGT, impaired glucose tolerance, T2D, type 2 diabetes.
###end p 49
###begin p 50
(0.02 MB DOC)
###end p 50
###begin p 51
Click here for additional data file.
###end p 51
###begin p 52
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 80 92 <span type="species:ncbi:9606">participants</span>
Anthropometrics and quantitative metabolic traits among normal-glucose tolerant participants in the population-based Inter99 study sample in relation to the rs2237897 genotypes of KCNQ1. The table includes unadjusted mean+/-S.D data for a total of 4,375 middle-aged individuals with normal glucose tolerance stratified according to genotype. P-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 52
###begin p 53
(0.03 MB DOC)
###end p 53
###begin p 54
Click here for additional data file.
###end p 54
###begin p 55
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 80 92 <span type="species:ncbi:9606">participants</span>
Anthropometrics and quantitative metabolic traits among normal-glucose tolerant participants in the population-based Inter99 study sample in relation to the rs2283228 genotypes of KCNQ1. The table includes unadjusted mean+/-S.D data for a total of 4,381 middle-aged individuals with normal glucose tolerance stratified according to genotype. P-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 55
###begin p 56
(0.03 MB DOC)
###end p 56
###begin p 57
Click here for additional data file.
###end p 57
###begin p 58
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 80 92 <span type="species:ncbi:9606">participants</span>
Anthropometrics and quantitative metabolic traits among normal-glucose tolerant participants in the population-based Inter99 study sample in relation to the rs2237892 genotypes of KCNQ1. The table includes unadjusted mean+/-S.D data for a total of 4,381 middle-aged individuals with normal glucose tolerance stratified according to genotype. P-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 58
###begin p 59
(0.03 MB DOC)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin p 61
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
Anthropometrics and quantitative metabolic traits in the population-based Inter99 study sample in relation to the rs2237897 genotypes of KCNQ1. Data are unadjusted mean+/-S.D data for a total of 5,776 middle-aged individuals with either normal glucose tolerance (n = 4,375), impaired fasting glycemia (n = 485), impaired glucose tolerance (n = 667) or screen-detected and treatment-naive type 2 diabetes (n = 249) stratified according to genotype. General linear regression analyses were used to calculate differences between geneotypes and p-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 61
###begin p 62
(0.03 MB DOC)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin p 64
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
Anthropometrics and quantitative metabolic traits in the population-based Inter99 study sample in relation to the rs2283228 genotypes of KCNQ1. Data are unadjusted mean+/-S.D data for a total of 5,787middle-aged individuals with either normal glucose tolerance (n = 4,381), impaired fasting glycemia (n = 491), impaired glucose tolerance (n = 667) or screen-detected and treatment-naive type 2 diabetes (n = 248) stratified according to genotype. General linear regression analyses were used to calculate differences between geneotypes and p-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 64
###begin p 65
(0.03 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
Anthropometrics and quantitative metabolic traits in the population-based Inter99 study sample in relation to the rs2237892 genotypes of KCNQ1. Data are unadjusted mean+/-S.D data for a total of 5,781 middle-aged individuals with either normal glucose tolerance (n = 4,381), impaired fasting glycemia (n = 483), impaired glucose tolerance (n = 672) or screen-detected and treatment-naive type 2 diabetes (n = 245) stratified according to genotype. General linear regression analyses were used to calculate differences between geneotypes and p-values shown are for an additive genetic model and are adjusted for age, BMI and sex. incAUC, incremental area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; BIGTT-SI, BIGTT-insulin sensitivity; BIGTT-AIR, BIGTT acute insulin response.
###end p 67
###begin p 68
(0.03 MB DOC)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
D' and r2 measures for the investigated KCNQ1 SNPs. Top triangle gives D' and bottom triangle gives r2-values.
###end p 70
###begin p 71
(0.02 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
The authors wish to thank Annemette Forman, Inge-Lise Wantzin, Tina Lorentzen, and Marianne Stendal for technical assistance, Grete Lademann for secretarial support, Arne Nielsen for data management and Michel Kristensen for scientific management duties.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
###end article-title 75
###begin article-title 76
Action potentials and insulin secretion: new insights into the role of Kv channels.
###end article-title 76
###begin article-title 77
Glucose-dependent regulation of rhythmic action potential firing in pancreatic beta-cells by KATP-channel modulation.
###end article-title 77
###begin article-title 78
Members of the Kv1 and Kv2 Voltage-Dependent K+ Channel Families Regulate Insulin Secretion.
###end article-title 78
###begin article-title 79
Inhibition of Kv2.1 Voltage-dependent K+ Channels in Pancreatic beta -Cells Enhances Glucose-dependent Insulin Secretion.
###end article-title 79
###begin article-title 80
Expression and Function of Pancreatic beta -Cell Delayed Rectifier K+ Channels. Role in Stimulus-Secretion Coupling.
###end article-title 80
###begin article-title 81
###xml 67 72 <span type="species:ncbi:10090">Mouse</span>
Pharmacological Properties and Functional Role of Kslow Current in Mouse Pancreatic {beta}-Cells: SK Channels Contribute to Kslow Tail Current and Modulate Insulin Secretion.
###end article-title 81
###begin article-title 82
Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.
###end article-title 82
###begin article-title 83
Polymorphisms in the gene encoding the voltage-dependent Ca2+ channel CaV2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion.
###end article-title 83
###begin article-title 84
Genome-wide association analysis identifies loci for Type 2 Diabetes and triglyceride levels.
###end article-title 84
###begin article-title 85
A genome-wide association study of Type 2 Diabetes in Finns detects multiple susceptibility variants.
###end article-title 85
###begin article-title 86
A genome-wide association study identifies novel risk loci for type 2 diabetes.
###end article-title 86
###begin article-title 87
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
###end article-title 87
###begin article-title 88
Replication of genome-wide association signals in UK samples reveals risk loci for Type 2 Diabetes.
###end article-title 88
###begin article-title 89
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.
###end article-title 89
###begin article-title 90
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus.
###end article-title 90
###begin article-title 91
Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.
###end article-title 91
###begin article-title 92
Genome-Wide Search for Type 2 Diabetes in Japanese Affected Sib-Pairs Confirms Susceptibility Genes on 3q, 15q, and 20q and Identifies Two New Candidate Loci on 7p and 11p.
###end article-title 92
###begin article-title 93
A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome.
###end article-title 93
###begin article-title 94
Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias.
###end article-title 94
###begin article-title 95
Common variants at ten loci influence QT interval duration in the QTGEN Study.
###end article-title 95
###begin article-title 96
Common variants at ten loci modulate the QT interval duration in the QTSCD Study.
###end article-title 96
###begin article-title 97
KCNQ potassium channels: physiology, pathophysiology, and pharmacology.
###end article-title 97
###begin article-title 98
hKCNE4 inhibits the hKCNQ1 potassium current without affecting the activation kinetics.
###end article-title 98
###begin article-title 99
Effects of IKs channel inhibitors in insulin-secreting INS-1 cells.
###end article-title 99
###begin article-title 100
QT interval, cardiovascular risk factors and risk of death in diabetes.
###end article-title 100
###begin article-title 101
The long QT syndrome. Prospective longitudinal study of 328 families.
###end article-title 101
###begin article-title 102
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human phenome-interactome network of protein complexes implicated in genetic disorders.
###end article-title 102
###begin article-title 103
Requirement of a Macromolecular Signaling Complex for beta Adrenergic Receptor Modulation of the KCNQ1-KCNE1 Potassium Channel.
###end article-title 103
###begin article-title 104
Mutation of an A-kinase-anchoring protein causes long-QT syndrome.
###end article-title 104
###begin article-title 105
Anchoring of protein kinase A facilitates hormone-mediated insulin secretion.
###end article-title 105
###begin article-title 106
Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with Type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
###end article-title 106
###begin article-title 107
Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: A study of 3734 subjects comprising three ethnicities living in Singapore.
###end article-title 107
###begin article-title 108
A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.
###end article-title 108
###begin article-title 109
The BIGTT Test: A novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.
###end article-title 109
###begin article-title 110
The generalization of student's ratio.
###end article-title 110
###begin article-title 111
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses.
###end article-title 111
###begin p 112
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: K. Borch-Johnsen, T. Hansen and O. Pedersen hold employee share in Novo Nordisk. The remaining authors declare that there is no duality of interest associated with this manuscript.
###end p 112
###begin p 113
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP), the Danish Medical Research Council, Novo Nordisk, the FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries, the Danish Diabetes Association, the European Union (EUGENE2, grant no. LSHM-CT-2004-512013), the Danish Agency for Science Technology and Innovation (grant no. 271-06-0539) and from the Swedish Research Council (J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 113

